Correlation Between Pharmaceuticals Ultrasector and Small-cap Value

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Small-cap Value at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Small-cap Value into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Small Cap Value Profund, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Small-cap Value and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Small-cap Value. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Small-cap Value.

Diversification Opportunities for Pharmaceuticals Ultrasector and Small-cap Value

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pharmaceuticals and Small-cap is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Small Cap Value Profund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Small Cap Value and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Small-cap Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Small Cap Value has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Small-cap Value go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Small-cap Value

Assuming the 90 days horizon Pharmaceuticals Ultrasector is expected to generate 17.41 times less return on investment than Small-cap Value. In addition to that, Pharmaceuticals Ultrasector is 1.02 times more volatile than Small Cap Value Profund. It trades about 0.01 of its total potential returns per unit of risk. Small Cap Value Profund is currently generating about 0.21 per unit of volatility. If you would invest  8,550  in Small Cap Value Profund on August 27, 2024 and sell it today you would earn a total of  626.00  from holding Small Cap Value Profund or generate 7.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pharmaceuticals Ultrasector Pr  vs.  Small Cap Value Profund

 Performance 
       Timeline  
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Small Cap Value 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Small Cap Value Profund are ranked lower than 8 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Small-cap Value may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pharmaceuticals Ultrasector and Small-cap Value Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmaceuticals Ultrasector and Small-cap Value

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Small-cap Value positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Small-cap Value can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Small-cap Value will offset losses from the drop in Small-cap Value's long position.
The idea behind Pharmaceuticals Ultrasector Profund and Small Cap Value Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance